
Opinion|Videos|September 3, 2025
Empowering Pharmacists in the Management of Patients With Urothelial Cancer
Listen
0:00 / 0:00
Sherry Vogt, PharmD, BCOP; and Megan Hinkley, PharmD, MBA, BCOP, discuss how pharmacists play a crucial role in managing patients with bladder cancer through treatment selection, patient education, adverse effect monitoring, and the evolving landscape of therapies including traditional chemotherapy, immunotherapy, and antibody-drug conjugates like enfortumab vedotin plus pembrolizumab.
Advertisement
0:13 Urothelial Cancer Background
9:08 Patient Education
15:45 Chemotherapy Toxicities
21:17 Unmet Needs
29:14 Antibody-Drug Conjugates
36:55 Adverse Event Management
42:30 Other Considerations
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Oral Semaglutide Approved to Reduce the Risk of Cardiovascular Events
2
Q&A: Pharmacists’ Role in Counseling Patients on Shingles Vaccination, Long-Term Health
3
Research Finds No Clinically Important Increase in Autism, ADHD Following Prenatal Paracetamol Use
4
Address Health Disparities Through Pharmacist-Led Initiatives in Underserved Communities
5











































































































































































































